Lorenz Studer

Dr. Studer is a scientific co-founder of BlueRock Therapeutics and is director of the Center for Stem Cell Biology and is a member of the Developmental Biology Program at Memorial Sloan Kettering in New York. He is currently leading a multidisciplinary consortium to pursue the clinical application of human stem cell-derived dopamine neurons for the treatment of Parkinson’s disease. Dr. Studer’s work has been recognized by numerous awards including the Boyer Young Investigator award, the Annemarie Opprecht Award, and a McArthur Fellowship.